As sequencing technologies become more affordable and bioinformatics tools more sophisticated, the use of WGS in cancer is expected to expand. Future research will likely focus on integrating WGS data with other omics approaches, such as transcriptomics and proteomics, to provide a more comprehensive understanding of cancer biology. Additionally, efforts to standardize WGS protocols and data interpretation guidelines will be crucial for its routine clinical use.